review · Neurological Sciences

The efficacy and safety of lecanemab 10 mg/kg biweekly compared to a placebo in patients with Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials

Karim Abdelazim
B. Mohamad Syahiirul Afifi
Ahmed Allam
Hebatullah Mohamed Abdulazeem
Ahmed I. Elbehiry

202412 citationsOpen accessAmerican University in Cairo

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Alzheimer's disease research and treatments
Dementia and Cognitive Impairment Research
Health Systems, Economic Evaluations, Quality of Life

Sustainable Development Goals

10Reduced Inequalities

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1007/s10072-024-07477-w

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.